Provectus Biopharmaceuticals Concludes FDA Meeting For PV-10 Phase 3; Successful Completion Of AB Science's Futility Test For Masitinib
February 10, 2015 at 05:59 AM EST
Here is a look at some of the headlines for companies that made news in the healthcare sector on February 9, 2015.
